In what populations is asthma becoming more prevalent, and is asthma becoming a significant public health issue? How can physicians better care for under-served communities with a prevalence of asthma? Dr. Michael Foggs, chief of allergy, asthma, and immunology at Advocate Health Centers, discusses the impact of asthma on under-served communities, and how physicians can be mindful of related socioeconomic issues. Hosted by Dr. Ketan Sheth.
Caring for Under-Served Communities With Asthma
Share this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Details
Presenters
Recommended
Details
Presenters
Overview
In what populations is asthma becoming more prevalent, and is asthma becoming a significant public health issue? How can physicians better care for under-served communities with a prevalence of asthma? Dr. Michael Foggs, chief of allergy, asthma, and immunology at Advocate Health Centers, discusses the impact of asthma on under-served communities, and how physicians can be mindful of related socioeconomic issues. Hosted by Dr. Ketan Sheth.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
MinuteCE®
HF Management for Patients with Comorbid Conditions
0.75 credits
<p>HF Management for Patients with Comorbid Conditions</p>
MinuteCE®
Level Up Your Skills: Tailoring Management of HF
0.75 credits
<p>Level Up Your Skills: Tailoring Management of HF</p>
CME/CE
Personalizing Care Within the RCC Treatment Paradigm
1.00 credits
<p>Personalizing Care Within the RCC Treatment Paradigm</p>
Clinician's Roundtable
AI and Hair Loss: Measuring Progress with Data-Driven Insights
<p>AI and Hair Loss: Measuring Progress with Data-Driven Insights</p>
Cardiology
Analysis of Patients With and Without AF Living With HFmrEF/HFpEF: FINEARTS-HF
<p>Analysis of Patients With and Without AF Living With HFmrEF/HFpEF: FINEARTS-HF</p>
Cardiology
FINE-HEART Pooled Analysis
<p><span data-teams="true">FINE-HEART Pooled Analysis</span></p>
Cardiology
Mode of Death in Patients With HFmrEF/HFpEF: The FINEARTS-HF Trial
<p><span data-teams="true">Mode of Death in Patients With HFmrEF/HFpEF: The FINEARTS-HF Trial</span> </p>
ACC Action Center
Semaglutide improves walking distance, symptoms and QoL in patients with PAD and T2D
<p>Semaglutide improves walking distance, symptoms and QoL in patients with PAD and T2D</p>
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?